Enveric Biosciences Inc. (ENVB)
NASDAQ: ENVB
· Real-Time Price · USD
0.90
0.18 (24.34%)
At close: Oct 15, 2025, 3:59 PM
0.88
-2.24%
After-hours: Oct 15, 2025, 04:39 PM EDT
24.34% (1D)
| Bid | 0.81 |
| Market Cap | 2.22M |
| Revenue (ttm) | 340.38K |
| Net Income (ttm) | -9.94M |
| EPS (ttm) | -9.97 |
| PE Ratio (ttm) | -0.09 |
| Forward PE | -0.02 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 0.89 |
| Volume | 4,443,700 |
| Avg. Volume (20D) | 404,967 |
| Open | 0.80 |
| Previous Close | 0.72 |
| Day's Range | 0.79 - 0.91 |
| 52-Week Range | 0.56 - 124.88 |
| Beta | 0.29 |
| Ex-Dividend Date | n/a |
About ENVB
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ENVB
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ENVB stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 week ago
+17.37%
Enveric Biosciences shares are trading higher afte...
Unlock content with
Pro Subscription
4 weeks ago
-29.3%
Enveric Biosciences shares are trading lower after the company announced an exercise of warrants for $2.2 million gross proceeds.
2 months ago · businesswire.com
Enveric Biosciences Reports Second Quarter 2025 Financial and Corporate ResultsCAMBRIDGE, Mass.--(BUSINESS WIRE)--Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company advancing next-generation neuroplastogenic small molecules to address psychi...
